Terms ending in 2044
Every in-force patent on Hoffmann-La Roche Inc.'s record whose computed term ends in 2044, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,133,726 | Detection of Gait Activity In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 12,770,713 | Generative Protein Design with Composable Energy-Based Models In force · Medium confidence | Genentech, Inc. | In force | Medium confidence | |
| US 12,458,567 | Adapter for Connecting a Dispenser to a Container In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 12,247,036 | Tricyclic Compounds for the Treatment of Cancer In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.